🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation. Read this State-of-the-Art review published in #EHJ 👉 ow.ly/Tenm50VSnw7 Rocco Montone EHJ Editor-in-Chief

Coronary artery bypass grafting with or without preoperative physiological stenosis assessment. Read the results of the SWEDEHEART study just published in #EHJ 👉 ow.ly/3g8350VXyVR Rocco Montone EHJ Editor-in-Chief

Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model. Read more in #EHJ 👉 ow.ly/ZVXw50VYGmp Rocco Montone EHJ Editor-in-Chief

The year in cardiovascular medicine 2024: the top 10 papers in diabetes and metabolic disorders. Discover more in #EHJ 👉 ow.ly/N9s650VYGqZ Rocco Montone EHJ Editor-in-Chief

Interruption of β-blocker treatment after an uncomplicated MI led to a sustained increase in BP and HR, with potentially deleterious effects on outcomes. Read the results of the AβYSS trial in #EHJ 👉 ow.ly/acyq50VYGrO Rocco Montone EHJ Editor-in-Chief

Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis. Read more in #EHJ 👉 ow.ly/wumV50W4Jwg Rocco Montone EHJ Editor-in-Chief #amyloidosis #aorticstenosis

What is the global economic burden of heart failure? Discover more in #EHJ 👉 ow.ly/ZTNS50W4JG4 Rocco Montone EHJ Editor-in-Chief #heartfailure

Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes. Read the results of the PREVENT trial in #EHJ 👉 ow.ly/yAGR50W4LwO Rocco Montone EHJ Editor-in-Chief

Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications. A State-of-the-Art review just published in #EHJ 👉 ow.ly/NZ7p50W4LLb Rocco Montone EHJ Editor-in-Chief

Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions. Read the results of the ILUMIEN IV trial in #EHJ 👉 ow.ly/OFif50W7yfX Rocco Montone EHJ Editor-in-Chief Ziad Ali Gregg W. Stone MD

Right heart catheterisation in heart failure: indications, interpretation, and pitfalls. Read this State-of-the-Art review just published in #EHJ 👉 ow.ly/8xaG50Wbn9p Rocco Montone EHJ Editor-in-Chief

Championing environmental sustainability in cardiology: the ESC Task Force’s vision for a healthier future. A Task Force with a mission. Read more in #EHJ 👉 ow.ly/G2qK50WevFi Rocco Montone EHJ Editor-in-Chief

A novel risk score for immune checkpoint inhibitor-associated myocarditis. Read more in #EHJ 👉 ow.ly/UU9O50WgHCP Rocco Montone EHJ Editor-in-Chief #CardioOncology #myocarditis

Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement. Read more in #EHJ 👉 ow.ly/teuC50WiZym Rocco Montone EHJ Editor-in-Chief

Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectives. A State-of-the-Art review just published in #EHJ 👉 ow.ly/36RT50WiZG8 Rocco Montone EHJ Editor-in-Chief

Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis. Read the results of a randomized trial published in #EHJ 👉 ow.ly/A4pX50Wl1i0 Rocco Montone EHJ Editor-in-Chief

Gene therapy and genome editing for lipoprotein disorders. A State-of-the-Art review just published in #EHJ 👉 ow.ly/sqqC50Wl1kQ Rocco Montone EHJ Editor-in-Chief #dyslipidemia

Refractory #angina: mechanisms and stratified treatment in obstructive and non-obstructive chronic myocardial ischaemic syndromes. Read this State-of-the-Art review in #EHJ 👉 ow.ly/oc5u50Wl1nn Rocco Montone EHJ Editor-in-Chief

Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures. Discover more in #EHJ 👉 ow.ly/3j7f50Wl1BO Rocco Montone EHJ Editor-in-Chief #TAVI #pollution

First myocardial infarction: risk factors, symptoms, and medical therapy. Read more in #EHJ 👉 ow.ly/gJvf50Wl1Gh Rocco Montone EHJ Editor-in-Chief